Table 2.
Identified Peptide ID | Function | Translocation Efficiency in Legionella,%a | MHC Allele | Sequence | Stimulation Indexb |
|
---|---|---|---|---|---|---|
After C. burnetii Infectionc | After Lm-Cb Receiptd | |||||
CBU2007200–208 | T4SS substrates | 90 | H-2-Db | FCYQNHTYF | 5.11 ± 0.11 | 5.32 ± 0.28 |
CBU205283–91 | T4SS substrates | 90 | H-2-Db | RASKNLLNY | 4.99 ± 0.24 | 7.99 ± 0.52 |
CBU1569173–181 | T4SS substrates | 90 | H-2-Db | FQISNPPYL | 4.78 ± 0.13 | 6.93 ± 1.46 |
CBU119827–35 | T4SS substrates | 75 | H-2-Kb | SVVNYATLF | 4.64 ± 0.29 | 2.34 ± 0.29 |
CBU1751360–368 | T4SS substrates | 50 | H-2-Db | VAIKSYRKF | 3.96 ± 0.15 | 7.59 ± 0.46 |
CBU2007292–300 | T4SS substrates | 90 | H-2-Kb | FVPKFFLTF | 3.73 ± 0.44 | 2.8 ± 0.52 |
CBU0414137–145 | T4SS substrates | 45 | H-2-Db | AQILNGDKL | 3.45 ± 0.46 | 1.28 ± 0.57 |
CBU1823136–144 | T4SS substrates | 50 | H-2-Db | SGICSVATY | 3.34 ± 0.04 | 4.59 ± 0.21 |
CBU0794327–335 | T4SS substrates | 80 | H-2-Db | SVNSNSGSF | 3.24 ± 0.2 | 4.84 ± 0.71 |
CBU2052236–244 | T4SS substrates | 90 | H-2-Kb | TVLLRTPLF | 3.13 ± 0.48 | 1.83 ± 0.32 |
CBU1460114–122 | T4SS substrates | 40 | H-2-Db | NALLDEETI | 3.11 ± 0.39 | 6.63 ± 0.48 |
CBU0881129–137 | T4SS substrates | 80 | H-2-Kb | VALFILTHL | 2.76 ± 0.44 | 1.94 ± 0.35 |
CBU0425320–328 | T4SS substrates | 90 | H-2-Kb | RVKVFLTHF | 2.72 ± 0.35 | 2.44 ± 0.04 |
CBU041026–34 | T4SS substrates | 45 | H-2-Db | NYATHKASY | 2.44 ± 0.13 | 2.48 ± 0.10 |
CBU042573–81 | T4SS substrates | 90 | H-2-Kb | ISLLRTLRY | 2.25 ± 0.06 | 1.91 ± 0.35 |
CBU1626(IcmG/DotF)37–45 | T4SS component | … | H-2-Kb | KPANFFVRF | 4.44 ± 0.2 | 2.47 ± 0.18 |
CBU1628(IcmK/DotH)20–28 | T4SS component | … | H-2-Kb | ASIIPVLAL | 3.93 ± 0.26 | 2.39 ± 0.18 |
CBU1648(DotA)5–13 | T4SS component | … | H-2-Db | SSLLASISL | 3.83 ± 0.22 | 7.61 ± 0.04 |
CBU1648(DotA)668–676 | T4SS component | … | H-2-Kb | IVVYTFSGL | 3.48 ± 0.2 | 2.87 ± 0.04 |
CBU1626(IcmG/DotF)52–60 | T4SS component | … | H-2-Kb | ITAVIAVVL | 2.97 ± 0.18 | 1.94 ± 0.09 |
CBU1628(IcmK/DotH)106–114 | T4SS component | … | H-2-Db | NTIRNMMPL | 2.94 ± 0.33 | 4.24 ± 0.10 |
CBU1628(IcmK/DotH)165–173 | T4SS component | … | H-2-Kb | SGFVTSLVF | 2.32 ± 0.26 | 2.42 ± 0.23 |
CBU_0311119–127 | Immunodominant | … | H-2-Kb | SNYSYRTRL | 4 ± 0.57 | 8.37 ± 0.67 |
CBU_009272–80 | Immunodominant | … | H-2-Kb | TVTHRLARL | 3.74 ± 0.57 | 8.28 ± 0.16 |
CBU_0092194–202 | Immunodominant | … | H-2-Kb | AQASFQNYL | 3.54 ± 0.15 | 9.04 ± 0.23 |
CBU_0311186–194 | Immunodominant | … | H-2-Kb | RHYFMNNVF | 3.49 ± 0.37 | 7.95 ± 0 |
CBU1910(Com1)213–221 | Immunodominant | … | H-2-Db | LQLAGTPTF | 3.45 ± 0.31 | 6.53 ± 0.32 |
CBU_1718181–189 | Immunodominant | … | H-2-Db | SGLENALEV | 2.84 ± 0.22 | 1.92 ± 0.40 |
CBU_0388770–778 | Immunodominant | … | H-2-Db | YSAQNEISF | 2.76 ± 0.15 | 2.34 ± 0.15 |
Abbreviations: ID, identifier; MHC, major histocompatibility complex; SD, standard deviation.
a The translocation efficiency of C. burnetii T4SS substrates by Legionella pneumophila is reported by Weber et al [21].
b The stimulation index was determined by an interferon γ enzyme-linked immunospot assay and was calculated using the number of spot-forming cells (SFCs) in peptide-stimulated cells divided by the number of SFCs in medium-stimulated cells. A stimulation index of > 2 was considered to be positive.
c A total of 2 × 105 CD8+ T cells were isolated on day 10 after infection from 5 mice infected with 1 × 106C. burnetii. Each peptide was added at a concentration of 2 µg/mL for 20 hours. The data presented are the mean (±SD) of 3 independent experiments.
d A total of 2 × 105 CD8+ T cells were isolated on day 10 after infection from 5 mice immunized with 5 × 106 Lm-Cb. Each peptide was added at a concentration of 2 µg/mL for 20 hours. The data presented are the mean (±SD) of 3 independent experiments.